SMX (NASDAQ:SMX) is addressing the enforcement gap in regulations by embedding molecular proof directly into materials, allowing for verifiable compliance and enforcement. This shift enables continuous compliance monitoring and eliminates loopholes, as seen in partnerships with Singapore, Europe, and North America. SMX's technology ensures that every product can carry its own proof of compliance, making regulations more effective and reliable.
SMX (NASDAQ:SMX) has made significant strides in addressing the enforcement gap in recycling regulations by embedding molecular proof directly into materials. This innovation allows for verifiable compliance and continuous monitoring, eliminating loopholes and enhancing the reliability of regulations. The company's technology enables every product to carry its own proof of compliance, making regulatory enforcement more effective and transparent.
SMX's latest partnership with a Miami plastics distributor to integrate its FDA-aligned molecular marker into food-grade rPET resin under 21 CFR rules marks a pivotal step in its global rollout. This move complements previous trials in Europe with REDWAVE and extrusion partnerships in Southeast Asia, forming a comprehensive strategy to verify recycled content globally
SMX Launches U.S. Partnership to Deploy FDA-Compliant Molecular Marking in rPET Plastics, Targets $50 billion Opportunity (NASDAQ: SMX)[1].
The integration of SMX's molecular marker into rPET under FDA regulations for Food Contact Substances (21 CFR) is particularly notable. This allows recycled material to enter premium, food-grade applications, a previously unattainable market for recycled plastics. By proving the origin and composition of recycled materials at the molecular level, SMX's technology addresses a common verification gap in the industry
SMX Launches U.S. Partnership to Deploy FDA-Compliant Molecular Marking in rPET Plastics, Targets $50 billion Opportunity (NASDAQ: SMX)[1].
Moreover, SMX links its molecular proof to blockchain-backed credits, such as the Plastic Cycle Token (PCT), providing a tradable identity for plastic waste. This monetization strategy transforms recycling from a compliance cost into a revenue stream, increasing the value of recycled materials
SMX Launches U.S. Partnership to Deploy FDA-Compliant Molecular Marking in rPET Plastics, Targets $50 billion Opportunity (NASDAQ: SMX)[1].
SMX's global strategy includes partnerships in Singapore, Europe, and North America, demonstrating the technology's applicability across different markets and regulatory environments. The company's ability to develop and implement such a comprehensive approach positions it as a leader in the recycling industry, addressing the challenges posed by low recycling rates and the need for verifiable recycled content
SMX Launches U.S. Partnership to Deploy FDA-Compliant Molecular Marking in rPET Plastics, Targets $50 billion Opportunity (NASDAQ: SMX)[1].
By embedding molecular proof directly into materials, SMX is not only enhancing regulatory compliance but also driving the transition to a more sustainable and circular economy. The company's technology ensures that every product carries its own proof of compliance, making regulations more effective and reliable. This shift is particularly significant in the context of rising demand for recycled plastics and the need for verifiable recycled content to meet sustainability targets
SMX Launches U.S. Partnership to Deploy FDA-Compliant Molecular Marking in rPET Plastics, Targets $50 billion Opportunity (NASDAQ: SMX)[1].
Comments
No comments yet